Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...

Newer evidence from the POP-RT phase III trial did show that pelvic nodal radiation for high-risk, locally advanced prostate ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging? Two previous trials have evaluated the role of ...

A new study at The Davidoff Comprehensive Cancer Center is examining the impact of reducing the number of radiation treatments needed for prostate cancer patients — and the news looks good so far.

How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...

Enrollment was between October 2019 and December 2023, during which time 41 patients were assessed for eligibility and 32 patients were enrolled. The median age was 74.0 years (range: 61.0-82.0), the ...

An interview with Dr. Scott Morgan from the Ottawa Hospital and University of Ottawa on "Hypofractionated Radiation Therapy for Localized Prostate Cancer: an ASTRO, ASCO, and AUA Evidence-Based ...

She has helped robots learn to get around indoors and pick up balls from the ground. And she has developed computer programs ...

A new imaging technology developed at UC Davis is set to revolutionize prostatectomy, the surgery to remove prostate cancer.